From confusion to clarity: Direct thrombin inhibitors for patients with heparin‐induced thrombocytopenia
- 28 March 2001
- journal article
- editorial comment
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 52 (4) , 473-475
- https://doi.org/10.1002/ccd.1103
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin‐induced thrombocytopenia undergoing percutaneous coronary intervention: Case reportsCatheterization and Cardiovascular Interventions, 2001
- Defining the Optimal Activated Clotting Time During Percutaneous Coronary InterventionCirculation, 2001
- Clinical Outcomes of Bivalirudin for Ischemic Heart DiseaseCirculation, 1999
- Platelet Activation With Unfractionated Heparin at Therapeutic Concentrations and Comparisons With a Low-Molecular-Weight Heparin and With a Direct Thrombin InhibitorCirculation, 1998
- Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO)Circulation, 1997
- Heparin-Induced Thrombocytopenia and ThrombosisNew England Journal of Medicine, 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJournal of the American College of Cardiology, 1993
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990